Related Experiment Video
Updated: Mar 21, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MiR-128 and miR-125 regulate expression of coagulation Factor IX gene with nonsense mutation by repressing
Gang Wang1, Baofeng Chai2, Linhua Yang1
1Department of Hematology, The Second Clinical Medical College, Shanxi Medical University, Taiyuan 030001, PR China.
Abstract:
Hemophilia could be caused by a nonsense mutation of the Factor IX gene, leading to a deficiency of Factor IX (F9). The nonsense mutation frequency of F9 is more than 10% according to the database. Nonsense-mediated mRNA decay (NMD) is a defined cellular response that can potentially prevent the production of such deleterious C-terminal truncated proteins from aberrant mRNA. Here, we constructed a mini-gene of Factor IX (Mini-hF9) and some nonsense mutants and characterized the mini-gene splicing pattern. We discovered that NMD regulated mini-hF9 expression in two nonsense mutants: E7a (nt 34 G>T in exon 7) and E7b (nt 52 G>T in exon 7), but not in another nonsense mutants: E7c (nt 85 G>T in exon 7) and E8 (nt 42 C>T in exon 8). In addition, mini-hF9 transcripts were accumulated after transfection with miR-128 or miR-125 mimics in E7a and E7b. Our results suggest that PTC (premature termination codon) location is a key determination for triggering NMD; miR-128 and miR-125 could help to increase the nonsense-mutant F9 levels by repressing NMD.
Insights
Nonsense mutations in the Factor IX gene cause hemophilia. Nonsense-mediated mRNA decay (NMD) regulates these mutations, with microRNAs potentially increasing Factor IX levels by repressing NMD.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Hemophilia can result from nonsense mutations in the Factor IX gene (F9), leading to Factor IX deficiency.
- Nonsense-mediated mRNA decay (NMD) is a cellular surveillance pathway that degrades aberrant mRNAs containing premature termination codons (PTCs).
Purpose of the Study:
- To investigate the role of NMD in regulating the expression of Factor IX (F9) variants with nonsense mutations.
- To determine the impact of PTC location on NMD efficiency for F9 transcripts.
- To explore the potential of microRNAs (miRNAs) in modulating NMD of F9 nonsense mutants.
Main Methods:
- Construction and characterization of a Factor IX mini-gene (Mini-hF9) with various nonsense mutations.
- Analysis of mini-gene splicing patterns and transcript levels.
- Transfection with miRNA mimics (miR-128, miR-125) to assess their effect on NMD.
Main Results:
- NMD regulated Mini-hF9 expression in specific nonsense mutants (E7a, E7b) but not others (E7c, E8).
- The location of the premature termination codon (PTC) was identified as a critical factor in triggering NMD.
- Transfection with miR-128 or miR-125 mimics led to the accumulation of mini-hF9 transcripts in affected mutants (E7a, E7b).
Conclusions:
- PTC position is a key determinant for NMD activation in Factor IX nonsense mutants.
- miR-128 and miR-125 can potentially enhance nonsense-mutant F9 levels by inhibiting NMD.
- These findings offer insights into therapeutic strategies for hemophilia by modulating mRNA decay pathways.
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
MicroRNAs
MicroRNAs
MicroRNAs
Experimental RNAi

